Cargando…

High expression of UBE2T predicts poor prognosis and survival in multiple myeloma

Multiple myeloma (MM) is one of hematological malignancies, characterized by malignant proliferation of plasma cells. Biomarkers play an important role in evaluating the development and prognosis of MM. Ubiquitin-conjugating enzyme E2T (UBE2T) is served to connect with particular E3 ubiquitin ligase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Weilong, Zhang, Ye, Yang, Zuozhen, Liu, Xiaoni, Yang, Ping, Wang, Jing, Hu, Kai, He, Xue, Zhang, Xiuru, Jing, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892417/ https://www.ncbi.nlm.nih.gov/pubmed/30622320 http://dx.doi.org/10.1038/s41417-018-0070-x

Ejemplares similares

High expression of CHML predicts poor prognosis of multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Prognosis value of RBBP8 expression in plasma cell myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Clinical prognostic implications of EPB41L4A expression in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2020)

Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2018)

High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia
por: Song, Ying, et al.
Publicado: (2019)

Dysregulation of N(6)-methyladenosine regulators predicts poor patient survival in mantle cell lymphoma
por: Zhang, Weilong, et al.
Publicado: (2019)

Exosome complex genes mediate RNA degradation and predict survival in mantle cell lymphoma
por: Zhang, Weilong, et al.
Publicado: (2019)

The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia
por: Cao, Ling, et al.
Publicado: (2019)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia
por: Lai, Rui, et al.
Publicado: (2020)

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
por: Guo, Yanjing, et al.
Publicado: (2023)

Increased Expression of SRSF1 Predicts Poor Prognosis in Multiple Myeloma
por: Zhang, Jiawei, et al.
Publicado: (2023)

Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
por: Liu, Xuewen, et al.
Publicado: (2017)

Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma
por: Xiang, Jing, et al.
Publicado: (2022)

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma
por: Zheng, Dong, et al.
Publicado: (2022)

FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2023)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022)

TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017)

UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

S1PR2 Knockdown Promotes Migration and Invasion in Multiple Myeloma Cells via NF-κB Activation
por: Pang, Meng, et al.
Publicado: (2020)

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
por: Barwick, Benjamin G., et al.
Publicado: (2019)

Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival
por: Di Lullo, Giulia, et al.
Publicado: (2015)

UBE2V2 promotes metastasis by regulating EMT and predicts a poor prognosis in lung adenocarcinoma
por: Yang, Zheng, et al.
Publicado: (2023)

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
por: He, JingSong, et al.
Publicado: (2021)

IgA Type Multiple Myeloma, Clinical Features, and Prognosis
por: Wang, Ling, et al.
Publicado: (2018)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
por: Walker, Brian A, et al.
Publicado: (2015)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
por: Noll, Jacqueline E., et al.
Publicado: (2015)

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
por: Ebert, Lisa M., et al.
Publicado: (2021)

PB2080: LOW DUP1 EXPRESSION PREDICTS POOR PROGNOSIS IN MULTIPLE MYELOMA
por: Lu, Jinfeng, et al.
Publicado: (2023)

Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression
por: Ren, Xiaoyue, et al.
Publicado: (2021)

ARNT/HIF‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
por: Wu, Chuan, et al.
Publicado: (2018)

Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma
por: Kim, Miyoung, et al.
Publicado: (2016)

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
por: Pawlyn, C, et al.
Publicado: (2017)

The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2023)

Overexpression of UBE2M through Wnt/β-Catenin signaling is associated with poor prognosis and chemotherapy resistance in colorectal cancer
por: Xu, Jianmin, et al.
Publicado: (2020)

Targeting Human β-Microglobulin with Monoclonal Antibodies in Multiple Myeloma - A Potential in Treatment
por: Zhang, Mingjun, et al.
Publicado: (2016)

Upregulated Circular RNA circ-UBE2D2 Predicts Poor Prognosis and Promotes Breast Cancer Progression by Sponging miR-1236 and miR-1287()
por: Wang, Yan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2v2ta3cj1bsfjv11puo558u6u9